BioSpace

Syntax Bio Announces Expanded Series A and Leadership Appointments

Company raises additional capital to advance Cellgorithm™ platform, develop pancreatic beta cell therapy for type 1 diabetes and strengthen leadership CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic ...
The New York Times

U.S. Bars Foreigners From Using Anthropic’s Most Advanced A.I. Models

The company said on Friday night that the federal government had ordered limits on its Mythos and Fable 5 A.I. systems, citing national security concerns. By Cade Metz and Dustin Volz Cade Metz ...
BioSpace

Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...